Exploring the potential and challenges of developing physiologically-based toxicokinetic models to support human health risk assessment of microplastic and nanoplastic particles

Microplastics (MPs) and nanoplastics (NPs) pollution has emerged as a significant and widespread environmental issue. Humans are inevitably exposed to MPs and NPs via ingestion, inhalation, and dermal contacts from various sources. However, mechanistic knowledge of their distribution, interaction, a...

Full description

Bibliographic Details
Main Authors: Chi-Yun Chen, Zhoumeng Lin
Format: Article
Language:English
Published: Elsevier 2024-04-01
Series:Environment International
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0160412024002034
_version_ 1797215996321202176
author Chi-Yun Chen
Zhoumeng Lin
author_facet Chi-Yun Chen
Zhoumeng Lin
author_sort Chi-Yun Chen
collection DOAJ
description Microplastics (MPs) and nanoplastics (NPs) pollution has emerged as a significant and widespread environmental issue. Humans are inevitably exposed to MPs and NPs via ingestion, inhalation, and dermal contacts from various sources. However, mechanistic knowledge of their distribution, interaction, and potency in the body is still lacking. To address this knowledge gap, we have undertaken the task of elucidating the toxicokinetic (TK) behaviors of MPs and NPs, aiming to provide mechanistic information for constructing a conceptual physiologically based toxicokinetic (PBTK) model to support in silico modeling approaches. Our effort involved a thorough examination of the existing literature and data collation on the presence of MPs in the human body and in vitro/ex vivo/in vivo biodistribution across various cells and tissues. By comprehending the absorption, distribution, metabolism, and excretion mechanisms of MPs and NPs in relation to their physicochemical attributes, we established a foundational understanding of the link between external exposure and internal tissue dosimetry. We observed that particle size and surface chemistry have been thoroughly explored in previous experimental studies. However, certain attributes, such as polymer type, shape, and biofilm/biocorona, warrant attention and further examination. We discussed the fundamental disparities in TK properties of MPs/NPs from those of engineered nanoparticles. We proposed a preliminary PBTK framework with several possible modeling approaches and discussed existing challenges for further investigation. Overall, this article provides a comprehensive compilation of existing TK data of MPs/NPs, a critical overview of TK processes and mechanisms, and proposes potential PBTK modeling approaches, particularly regarding their applicability to the human system, and outlines future perspectives for developing PBTK models and their integration into human health risk assessment of MPs and NPs.
first_indexed 2024-04-24T11:38:56Z
format Article
id doaj.art-f7b491913b974d6e9cd44b4c7c031033
institution Directory Open Access Journal
issn 0160-4120
language English
last_indexed 2024-04-24T11:38:56Z
publishDate 2024-04-01
publisher Elsevier
record_format Article
series Environment International
spelling doaj.art-f7b491913b974d6e9cd44b4c7c0310332024-04-10T04:28:28ZengElsevierEnvironment International0160-41202024-04-01186108617Exploring the potential and challenges of developing physiologically-based toxicokinetic models to support human health risk assessment of microplastic and nanoplastic particlesChi-Yun Chen0Zhoumeng Lin1Department of Environmental and Global Health, College of Public Health and Health Professions, University of Florida, Gainesville, FL 32610, United States; Center for Environmental and Human Toxicology, University of Florida, FL 32608, United StatesDepartment of Environmental and Global Health, College of Public Health and Health Professions, University of Florida, Gainesville, FL 32610, United States; Center for Environmental and Human Toxicology, University of Florida, FL 32608, United States; Corresponding author.Microplastics (MPs) and nanoplastics (NPs) pollution has emerged as a significant and widespread environmental issue. Humans are inevitably exposed to MPs and NPs via ingestion, inhalation, and dermal contacts from various sources. However, mechanistic knowledge of their distribution, interaction, and potency in the body is still lacking. To address this knowledge gap, we have undertaken the task of elucidating the toxicokinetic (TK) behaviors of MPs and NPs, aiming to provide mechanistic information for constructing a conceptual physiologically based toxicokinetic (PBTK) model to support in silico modeling approaches. Our effort involved a thorough examination of the existing literature and data collation on the presence of MPs in the human body and in vitro/ex vivo/in vivo biodistribution across various cells and tissues. By comprehending the absorption, distribution, metabolism, and excretion mechanisms of MPs and NPs in relation to their physicochemical attributes, we established a foundational understanding of the link between external exposure and internal tissue dosimetry. We observed that particle size and surface chemistry have been thoroughly explored in previous experimental studies. However, certain attributes, such as polymer type, shape, and biofilm/biocorona, warrant attention and further examination. We discussed the fundamental disparities in TK properties of MPs/NPs from those of engineered nanoparticles. We proposed a preliminary PBTK framework with several possible modeling approaches and discussed existing challenges for further investigation. Overall, this article provides a comprehensive compilation of existing TK data of MPs/NPs, a critical overview of TK processes and mechanisms, and proposes potential PBTK modeling approaches, particularly regarding their applicability to the human system, and outlines future perspectives for developing PBTK models and their integration into human health risk assessment of MPs and NPs.http://www.sciencedirect.com/science/article/pii/S0160412024002034MicroplasticsNanoplasticsphysiologically based kinetic (PBK)physiologically based pharmacokinetic (PBPK)ToxicokineticsHuman health risk assessment
spellingShingle Chi-Yun Chen
Zhoumeng Lin
Exploring the potential and challenges of developing physiologically-based toxicokinetic models to support human health risk assessment of microplastic and nanoplastic particles
Environment International
Microplastics
Nanoplastics
physiologically based kinetic (PBK)
physiologically based pharmacokinetic (PBPK)
Toxicokinetics
Human health risk assessment
title Exploring the potential and challenges of developing physiologically-based toxicokinetic models to support human health risk assessment of microplastic and nanoplastic particles
title_full Exploring the potential and challenges of developing physiologically-based toxicokinetic models to support human health risk assessment of microplastic and nanoplastic particles
title_fullStr Exploring the potential and challenges of developing physiologically-based toxicokinetic models to support human health risk assessment of microplastic and nanoplastic particles
title_full_unstemmed Exploring the potential and challenges of developing physiologically-based toxicokinetic models to support human health risk assessment of microplastic and nanoplastic particles
title_short Exploring the potential and challenges of developing physiologically-based toxicokinetic models to support human health risk assessment of microplastic and nanoplastic particles
title_sort exploring the potential and challenges of developing physiologically based toxicokinetic models to support human health risk assessment of microplastic and nanoplastic particles
topic Microplastics
Nanoplastics
physiologically based kinetic (PBK)
physiologically based pharmacokinetic (PBPK)
Toxicokinetics
Human health risk assessment
url http://www.sciencedirect.com/science/article/pii/S0160412024002034
work_keys_str_mv AT chiyunchen exploringthepotentialandchallengesofdevelopingphysiologicallybasedtoxicokineticmodelstosupporthumanhealthriskassessmentofmicroplasticandnanoplasticparticles
AT zhoumenglin exploringthepotentialandchallengesofdevelopingphysiologicallybasedtoxicokineticmodelstosupporthumanhealthriskassessmentofmicroplasticandnanoplasticparticles